ozempic versus semaglutide vs Mounjaro: Comparing GLP‑1 Injectable Weight‑Loss Meds, vs Tirzepatide, and Real Side Effects Judge Upholds FDA Deadline Ending

Demand for GLP1s is growing at a pace few treatments have matched

A civil investigative demand issued in May seeks information about the marketing and sale of research-grade GLP-1s by sellers on that platform, some of whom allegedly promote the drugs as injectable weight loss treatments and offer to ship them in packaging designed to evade customs

Rotating injection sites is the primary prevention strategy

Drinking enough water, eating smaller meals, and avoiding heavy foods may help make the adjustment period easier

Practical screening guidanceincluding cut-offs and tools for PHQ-9, BES, and others is provided in the next chapter